The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 11, 2025

Filed:

Oct. 13, 2020
Applicant:

Koninklijke Philips N.v., Eindhoven, NL;

Inventors:

Bernardus Hendrikus Wilhelmus Hendriks, Eindhoven, NL;

Maria-Louisa Izamis, Cambridge, MA (US);

Caifeng Shan, Veldhoven, NL;

Assignee:

KONINKLIJJKE PHILIPS N.V., Eindhoven, NL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 6/00 (2024.01); A61B 6/46 (2024.01); A61B 6/50 (2024.01); G16H 30/40 (2018.01);
U.S. Cl.
CPC ...
A61B 6/5217 (2013.01); A61B 6/4417 (2013.01); A61B 6/463 (2013.01); A61B 6/481 (2013.01); A61B 6/507 (2013.01); A61B 6/5247 (2013.01); A61B 6/5264 (2013.01); G16H 30/40 (2018.01);
Abstract

Perfusion angiography combined with photoplethysmography imaging for peripheral vascular disease assessment A device () and method for performing perfusion imaging receive image sequences that are acquired simultaneously by an X-ray imaging apparatus () and by a photoplethysmography imaging apparatus (). When temporally aligned, changes in the perfusion states of a perfused organic tissue over time are extracted from the two image sequences and an image is generated for display on a display unit () which indicates the changes in the perfusion states at various locations of the perfused organ tissue, thereby capturing both deep organ tissue and superficial organ tissue perfusion properties. A diminution in an image signal strength in the photoplethysmography images caused by a passage of a bolus comprising a previously administered contrast agent () can be used to align the two concurrently acquired image sequences in time.


Find Patent Forward Citations

Loading…